Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (81-90 of 539) with videos related to

Pageof 54
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokineticsChristos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, et al.
Cancers|May 28, 2020
Can <sup>18</sup>F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?Christos Sachpekidis, Annette Kopp-Schneider, Maximilian Merz, et al.
Blood|December 19, 2009
IL-6 and MYC collaborate in plasma cell tumor formation in miceSebastian Rutsch, Vishala T Neppalli, Dong-Mi Shin, et al.
British Journal of Cancer|December 7, 2018
Cell-based immunotherapy approaches for multiple myelomaKatharina Kriegsmann, Mark Kriegsmann, Martin Cremer, et al.
Molecular Cancer Therapeutics|October 23, 2012
Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitorsJérôme Moreaux, Thierry Rème, Wim Leonard, et al.
Plos One|May 7, 2013
Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cellsAlboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Familial Cancer: How to Successfully Recruit Families for Germline Mutations Studies? Multiple Myeloma as an ExampleJoanna Blocka, Brian G M Durie, Stefanie Huhn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2009
Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantationPatrick Wuchter, Dan Ran, Thomas Bruckner, et al.
Histopathology|November 21, 2013
Expression of Mucin-1 in multiple myeloma and its precursors: correlation with glycosylation and subcellular localizationMindaugas Andrulis, Elena Ellert, Ulla Mandel, et al.
Blood Cancer Journal|January 22, 2019
Patients with precursor disease exhibit similar psychological distress and mental HRQOL as patients with active myelomaImad Maatouk, Susanne He, Manuela Hummel, et al.
Pageof 54

Showing results (81-90 of 539) with videos related to

Sort By:
Pageof 54
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokineticsChristos Sachpekidis, Hartmut Goldschmidt, Dirk Hose, et al.
Cancers|May 28, 2020
Can <sup>18</sup>F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?Christos Sachpekidis, Annette Kopp-Schneider, Maximilian Merz, et al.
Blood|December 19, 2009
IL-6 and MYC collaborate in plasma cell tumor formation in miceSebastian Rutsch, Vishala T Neppalli, Dong-Mi Shin, et al.
British Journal of Cancer|December 7, 2018
Cell-based immunotherapy approaches for multiple myelomaKatharina Kriegsmann, Mark Kriegsmann, Martin Cremer, et al.
Molecular Cancer Therapeutics|October 23, 2012
Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitorsJérôme Moreaux, Thierry Rème, Wim Leonard, et al.
Plos One|May 7, 2013
Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cellsAlboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 5, 2019
Familial Cancer: How to Successfully Recruit Families for Germline Mutations Studies? Multiple Myeloma as an ExampleJoanna Blocka, Brian G M Durie, Stefanie Huhn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2009
Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantationPatrick Wuchter, Dan Ran, Thomas Bruckner, et al.
Histopathology|November 21, 2013
Expression of Mucin-1 in multiple myeloma and its precursors: correlation with glycosylation and subcellular localizationMindaugas Andrulis, Elena Ellert, Ulla Mandel, et al.
Blood Cancer Journal|January 22, 2019
Patients with precursor disease exhibit similar psychological distress and mental HRQOL as patients with active myelomaImad Maatouk, Susanne He, Manuela Hummel, et al.
Pageof 54